Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07527143
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
45 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Key Dates

First listed
Apr 14, 2026
Start date
Jun 10, 2026
Status verified
Jul 2026
Primary completion
Jun 10, 2027
Completion
Jun 10, 2027

Study Design

Enrollment
25 participants (estimated)

Arms

  • Arm: Observational
    Participants complete a semi-structured interview on study.

Primary Outcome Measure

Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test [ Time Frame: Baseline (30-minute virtual interview) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
855-776-0015
Kelly Gunderson
507-422-1892
Shariska Harrington, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Nationwide
Endometrial cancer trialsOncology trialsGynecologic oncology trialsWomen's health trials
By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies